72.74
price down icon1.29%   -0.95
after-market Handel nachbörslich: 72.00 -0.74 -1.02%
loading
Schlusskurs vom Vortag:
$73.69
Offen:
$73.5
24-Stunden-Volumen:
2.76M
Relative Volume:
1.25
Marktkapitalisierung:
$13.25B
Einnahmen:
$381.03M
Nettoeinkommen (Verlust:
$-1.01B
KGV:
-12.23
EPS:
-5.95
Netto-Cashflow:
$-789.25M
1W Leistung:
+5.10%
1M Leistung:
+0.22%
6M Leistung:
-3.44%
1J Leistung:
+25.78%
1-Tages-Spanne:
Value
$72.31
$74.98
1-Wochen-Bereich:
Value
$67.81
$74.98
52-Wochen-Spanne:
Value
$55.74
$84.91

Insmed Inc Stock (INSM) Company Profile

Name
Firmenname
Insmed Inc
Name
Telefon
908-977-9900
Name
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Mitarbeiter
1,271
Name
Twitter
@insmed
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
INSM's Discussions on Twitter

Vergleichen Sie INSM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INSM
Insmed Inc
72.74 12.61B 381.03M -1.01B -789.25M -5.95
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Insmed Inc Stock (INSM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-13 Eingeleitet Jefferies Buy
2025-02-25 Eingeleitet RBC Capital Mkts Outperform
2024-04-23 Eingeleitet Truist Buy
2024-02-15 Eingeleitet Wolfe Research Outperform
2023-12-08 Eingeleitet Wells Fargo Overweight
2023-11-20 Fortgesetzt JP Morgan Overweight
2023-07-26 Eingeleitet Guggenheim Buy
2022-12-09 Eingeleitet Mizuho Buy
2022-12-07 Eingeleitet Barclays Overweight
2022-11-18 Eingeleitet BofA Securities Buy
2022-04-27 Eingeleitet Goldman Buy
2021-12-06 Eingeleitet JP Morgan Overweight
2021-10-19 Fortgesetzt Monness Crespi & Hardt Buy
2021-10-19 Fortgesetzt Morgan Stanley Overweight
2021-10-08 Eingeleitet Cantor Fitzgerald Overweight
2021-04-26 Fortgesetzt Credit Suisse Outperform
2020-12-17 Eingeleitet Berenberg Buy
2020-10-12 Fortgesetzt Stifel Buy
2019-09-03 Eingeleitet Goldman Buy
2019-04-09 Bestätigt H.C. Wainwright Buy
2019-02-15 Hochstufung JMP Securities Mkt Perform → Mkt Outperform
2019-01-17 Hochstufung Goldman Neutral → Buy
2019-01-02 Eingeleitet Canaccord Genuity Buy
2018-08-06 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2018-07-23 Eingeleitet Goldman Neutral
2018-04-23 Hochstufung Credit Suisse Neutral → Outperform
2018-03-21 Eingeleitet Morgan Stanley Overweight
2018-01-18 Eingeleitet Credit Suisse Neutral
2017-09-05 Bestätigt Evercore ISI Outperform
2017-08-17 Eingeleitet Evercore ISI Outperform
2017-07-11 Eingeleitet Robert W. Baird Outperform
2016-03-15 Eingeleitet Stifel Buy
2015-11-09 Herabstufung UBS Buy → Neutral
2015-10-06 Bestätigt H.C. Wainwright Buy
2015-06-09 Eingeleitet Citigroup Neutral
2014-03-26 Bestätigt HC Wainwright Buy
Alle ansehen

Insmed Inc Aktie (INSM) Neueste Nachrichten

pulisher
12:26 PM

Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate UpdatesA... - ADVFN

12:26 PM
pulisher
Jun 04, 2025

Insider Sell Alert: MCGIRR DAVID W J Sells 6,250 Shares of Insme - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

INSMED Executives Conduct Series of Stock Transactions - TradingView

Jun 04, 2025
pulisher
Jun 04, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | INSM Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Insmed Accelerates Growth: 150 New Hires Receive $10M+ in Stock Awards and Options - Stock Titan

Jun 04, 2025
pulisher
Jun 03, 2025

Insider Sell: Michael Smith Sells 26,327 Shares of Insmed Inc (I - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Insmed Breaks Above 200-Day Moving AverageBullish for INSM - Nasdaq

Jun 03, 2025
pulisher
May 28, 2025

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga

May 28, 2025
pulisher
May 28, 2025

Insmed To Present at the 2025 Goldman Sachs Annual Global Health - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Insmed To Present at the 2025 Goldman Sachs Annual Global Healthcare Conference - marketscreener.com

May 28, 2025
pulisher
May 27, 2025

Insmed’s SWOT analysis: rare disease biotech stock shows promise amid challenges - Investing.com

May 27, 2025
pulisher
May 26, 2025

Insmed Incorporated (NASDAQ:INSM) Shares Purchased by Cetera Investment Advisers - Defense World

May 26, 2025
pulisher
May 23, 2025

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - GlobeNewswire Inc.

May 23, 2025
pulisher
May 21, 2025

Insmed Says Brensocatib Showed Consistent Efficacy in Non-Cystic Fibrosis Bronchiectasis - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

Insmed (INSM) Highlights Promising Brensocatib Trial Results at - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Insmed (INSM) Highlights Promising Brensocatib Trial Results at ATS 2025 | INSM Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Captrust Financial Advisors Sells 631 Shares of Insmed Incorporated (NASDAQ:INSM) - Defense World

May 20, 2025
pulisher
May 17, 2025

Mercer Global Advisors Inc. ADV Acquires New Position in Insmed Incorporated (NASDAQ:INSM) - Defense World

May 17, 2025
pulisher
May 16, 2025

HC Wainwright Issues Optimistic Outlook for Insmed Earnings - Defense World

May 16, 2025
pulisher
May 15, 2025

INSMED Executives Sell Shares to Satisfy Tax Obligations - TradingView

May 15, 2025
pulisher
May 15, 2025

Jefferies Financial Group Initiates Coverage on Insmed (NASDAQ:INSM) - Defense World

May 15, 2025
pulisher
May 14, 2025

Jefferies Initiates Coverage of Insmed (BIT:1INSM) with Buy Recommendation - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Insmed Incorporated (INSM): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Jefferies Initiates Coverage of Insmed (BMV:INSM) with Buy Recommendation - Nasdaq

May 14, 2025
pulisher
May 13, 2025

Jefferies sets $105 target on Insmed stock with Buy rating By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Insmed at Bank of America 2025 Healthcare Conference: Strategic Pipeline Focus - Investing.com

May 13, 2025
pulisher
May 13, 2025

Jefferies Initiates Coverage on INSM with a Buy Rating and $105 PT | INSM Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Jefferies Initiates Coverage of Insmed (LSE:0JAV) with Buy Recommendation - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Unlocking Insmed (INSM) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

May 13, 2025
pulisher
May 13, 2025

Jefferies Initiates Coverage of Insmed (INSM) with Buy Recommendation - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Jefferies Initiates Coverage on Insmed With Buy Rating, $105 Price Target - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Jefferies sets $105 target on Insmed stock with Buy rating - Investing.com

May 13, 2025
pulisher
May 13, 2025

Insmed (NASDAQ:INSM) Given Buy Rating at HC Wainwright - Defense World

May 13, 2025
pulisher
May 12, 2025

Insmed (INSM) Gains Buy Rating from Jefferies with Promising Out - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Insmed (INSM) Receives Reaffirmed Buy Rating from HC Wainwright - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Analyst Expectations For Insmed's Future - Benzinga

May 12, 2025
pulisher
May 12, 2025

Insmed Incorporated (NASDAQ:INSM) Given Consensus Rating of “Buy” by Analysts - Defense World

May 12, 2025
pulisher
May 12, 2025

UBS Group Cuts Insmed (NASDAQ:INSM) Price Target to $109.00 - Defense World

May 12, 2025
pulisher
May 12, 2025

Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 12, 2025
pulisher
May 11, 2025

Analysts Are Updating Their Insmed Incorporated (NASDAQ:INSM) Estimates After Its First-Quarter Results - Yahoo Finance

May 11, 2025
pulisher
May 10, 2025

Insmed Incorporated (NASDAQ:INSM) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Insmed (INSM) Receives Slight Price Target Adjustment by UBS | I - GuruFocus

May 09, 2025
pulisher
May 09, 2025

UBS Maintains Buy Rating, Lowers Price Target for Insmed (INSM) - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Insmed's Q1 Loss Wider Than Expected, Sales Match Estimates - TradingView

May 09, 2025
pulisher
May 09, 2025

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga

May 09, 2025
pulisher
May 09, 2025

Is Insmed Incorporated (INSM) the Best Cancer Stock to Invest in for Long-Term Gain? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Insmed (INSM) Receives Slight Price Target Adjustment by UBS | INSM Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

RBC Trims Price Target on Insmed to $99 From $100, Keeps Outperform Rating - marketscreener.com

May 09, 2025

Finanzdaten der Insmed Inc-Aktie (INSM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Insmed Inc-Aktie (INSM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Flammer Martina M.D.
Chief Medical Officer
Jun 03 '25
Sale
71.50
1,686
120,549
83,111
Adsett Roger
Chief Operating Officer
Jun 03 '25
Sale
71.50
1,860
132,990
141,323
Bonstein Sara
Chief Financial Officer
Jun 03 '25
Sale
71.50
1,579
112,898
113,288
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Jun 03 '25
Sale
71.50
1,642
117,403
118,579
MCGIRR DAVID W J
Director
Jun 03 '25
Sale
71.30
3,250
231,725
100,723
MCGIRR DAVID W J
Director
Jun 04 '25
Sale
73.27
3,000
219,810
97,723
Lewis William
Chair and CEO
Jun 02 '25
Option Exercise
10.85
6,830
74,106
240,754
Lewis William
Chair and CEO
Jun 02 '25
Sale
71.31
6,830
487,044
233,924
Lewis William
Chair and CEO
Jun 03 '25
Sale
71.50
5,472
391,248
308,758
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Kapitalisierung:     |  Volumen (24h):